The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Liquid Biopsy: General Concepts
Abstract
Liquid biopsy provides the opportunity of detecting, analyzing and monitoring cancer in various body effluents such as blood or urine instead of a fragment of cancer tissue. It is composed of different biological matrices such as circulating tumor cells (CTCs), cell free nucleic acids, exosomes or tumors “educated platelets.” In addition to representing a non- or minimally invasive procedure, it should represent a better view of tumor heterogeneity and allows for real-time monitoring of cancer evolution. Recent technological and molecular advances, greatly facilitated by the use of microfluidics in many cases, have permitted large progresses both in our ability to purify and analyze liquid biopsy components. In particular, the great developments of droplet-based digital PCR and the various optimizations of next generation sequencing technologies are central to the several validations of CTC-free DNA as a strong cancer biomarker. However, complete adoption of liquid biopsy in clinics will require pursuing recent efforts in the standardization of procedures both on the pre-analytical and analytical aspects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
The role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
EV-TRACK Consortium, Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., Martinez, Z. A., Baetens, T., Beghein, E., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4185 · Cited by 1,284
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082
The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling
Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V., Vermaelen, K., Vandesompele, J., Bracke, M., De Wever, O., & Hendrix, A. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24858 · Cited by 938
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine
Contreras-Naranjo, J. C., Wu, H.-J., & Ugaz, V. M. (2017) · Lab on a Chip · doi:10.1039/c7lc00592j · Cited by 640
Tie, J., Kinde, I., Wang, Y., Wong, H. L., Roebert, J., Christie, M., Tacey, M., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 635
Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M. T., Allen, P. J., Schattner, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 582
Sacher, A. G., Paweletz, C., Dahlberg, S. E., Alden, R. S., O’Connell, A., Feeney, N., Mach, S. L., Jänne, P. A., & Oxnard, G. R. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0173 · Cited by 571
Wang, Y., Springer, S., Mulvey, C. L., Silliman, N., Schaefer, J., Sausen, M., James, N., Rettig, E. M., Guo, T., Pickering, C. R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8507 · Cited by 500
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Reinert, T., Schøler, L. V., Thomsen, R., Tobiasen, H., Vang, S., Nordentoft, I., Lamy, P., Kannerup, A.-S., Mortensen, F. V., Stribolt, K., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308859 · Cited by 463
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448
Leukemia cell to endothelial cell communication via exosomal miRNAs
Umezu, T., Ohyashiki, K., Kuroda, M., & Ohyashiki, J. H. (2013) · Oncogene · doi:10.1038/onc.2012.295 · Cited by 448
Considerations for Digital PCR as an Accurate Molecular Diagnostic Tool
Huggett, J. F., Cowen, S., & Foy, C. A. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.221366 · Cited by 444
Blood platelets contain tumor-derived RNA biomarkers
Nilsson, R. J. A., Balaj, L., Hulleman, E., van Rijn, S., Pegtel, D. M., Walraven, M., Widmark, A., Gerritsen, W. R., Verheul, H. M., Vandertop, W. P., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344408 · Cited by 399
Challenges in circulating tumor cell detection by the CellSearch system
Andree, K. C., van Dalum, G., & Terstappen, L. W. M. M. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.002 · Cited by 363
Platelets actively sequester angiogenesis regulators
Lakka Klement, G., Yip, T.-T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., Italiano, J. E., Wheatley, E., Abou-Slaybi, A., Bender, E., et al. (2009) · Blood · doi:10.1182/blood-2008-06-159541 · Cited by 346
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
Russo, M., Misale, S., Wei, G., Siravegna, G., Crisafulli, G., Lazzari, L., Corti, G., Rospo, G., Novara, L., Mussolin, B., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0940 · Cited by 308
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Schøler, L. V., Reinert, T., Ørntoft, M.-B. W., Kassentoft, C. G., Árnadóttir, S. S., Vang, S., Nordentoft, I., Knudsen, M., Lamy, P., Andreasen, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0510 · Cited by 306
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Pan, W., Gu, W., Nagpal, S., Gephart, M. H., & Quake, S. R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.235457 · Cited by 297
The role of exosomes and miRNAs in drug‐resistance of cancer cells
Bach, D., Hong, J., Park, H. J., & Lee, S. K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30669 · Cited by 296
O’Brien, K., Lowry, M. C., Corcoran, C., Martinez, V. G., Daly, M., Rani, S., Gallagher, W. M., Radomski, M. W., MacLeod, R. A. F., & O’Driscoll, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5192 · Cited by 273
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Pietrasz, D., Pécuchet, N., Garlan, F., Didelot, A., Dubreuil, O., Doat, S., Imbert-Bismut, F., Karoui, M., Vaillant, J.-C., Taly, V., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0806 · Cited by 268
Self-citationMisale, S., Arena, S., Lamba, S., Siravegna, G., Lallo, A., Hobor, S., Russo, M., Buscarino, M., Lazzari, L., Sartore-Bianchi, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007947 · Cited by 263
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm0715-827b · Cited by 255
Postel, M., Roosen, A., Laurent-Puig, P., Taly, V., & Wang-Renault, S.-F. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 254
Self-citationExosomal miRNAs as novel cancer biomarkers: Challenges and opportunities
Salehi, M., & Sharifi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26481 · Cited by 251
Technologies for detection of circulating tumor cells: facts and vision
Alix-Panabières, C., & Pantel, K. (2014) · Lab Chip · doi:10.1039/c3lc50644d · Cited by 250
Garlan, F., Laurent-Puig, P., Sefrioui, D., Siauve, N., Didelot, A., Sarafan-Vasseur, N., Michel, P., Perkins, G., Mulot, C., Blons, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3155 · Cited by 250
Self-citationGuibert, N., Delaunay, M., Lusque, A., Boubekeur, N., Rouquette, I., Clermont, E., Mourlanette, J., Gouin, S., Dormoy, I., Favre, G., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.001 · Cited by 236
Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer
Bhome, R., Del Vecchio, F., Lee, G.-H., Bullock, M. D., Primrose, J. N., Sayan, A. E., & Mirnezami, A. H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.002 · Cited by 223
Circulating tumor cells: clinical validity and utility
Cabel, L., Proudhon, C., Gortais, H., Loirat, D., Coussy, F., Pierga, J.-Y., & Bidard, F.-C. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1105-2 · Cited by 219
The Multiple Roles of Exosomes in Metastasis
WEIDLE, U. H., BIRZELE, F., KOLLMORGEN, G., & RÜGER, R. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20015 · Cited by 185
Bachet, J. B., Bouché, O., Taieb, J., Dubreuil, O., Garcia, M. L., Meurisse, A., Normand, C., Gornet, J. M., Artru, P., Louafi, S., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy061 · Cited by 178
Self-citationCirculating Tumor Cells: Moving Biological Insights into Detection
Chen, L., Bode, A. M., & Dong, Z. (2017) · Theranostics · doi:10.7150/thno.18588 · Cited by 150
Significant Downregulation of Platelet Gene Expression in Metastatic Lung Cancer
Calverley, D. C., Phang, T. L., Choudhury, Q. G., Gao, B., Oton, A. B., Weyant, M. J., & Geraci, M. W. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00226.x · Cited by 136
Perkins, G., Lu, H., Garlan, F., & Taly, V. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.10.001 · Cited by 131
Self-citationEx Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
Maheswaran, S., & Haber, D. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0145 · Cited by 112
Soh, J., Toyooka, S., Aoe, K., Asano, H., Ichihara, S., Katayama, H., Hiraki, A., Kiura, K., Aoe, M., Sano, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22190 · Cited by 110
Manceau, G., Imbeaud, S., Thiébaut, R., Liébaert, F., Fontaine, K., Rousseau, F., Génin, B., Corre, D. L., Didelot, A., Vincent, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2750 · Cited by 108
Pécuchet, N., Zonta, E., Didelot, A., Combe, P., Thibault, C., Gibault, L., Lours, C., Rozenholc, Y., Taly, V., Laurent‐Puig, P., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002199 · Cited by 99
Self-citationFunctional Studies on Viable Circulating Tumor Cells
Pantel, K., & Alix‐Panabières, C. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242537 · Cited by 96
Quantification of microRNA levels in plasma – Impact of preanalytical and analytical conditions
Binderup, H. G., Madsen, J. S., Heegaard, N. H. H., Houlind, K. C., Andersen, R. F., & Brasen, C. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201069 · Cited by 90
Boeckx, N., de Beeck, K. O., Beyens, M., Deschoolmeester, V., Hermans, C., Clercq, P. D., Garrigou, S., Normand, C., Monsaert, E., Papadimitriou, K., et al. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.02.006 · Cited by 55
Self-citationLiquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers
Venesio, T., Siravegna, G., Bardelli, A., & Sapino, A. (2017) · Pathobiology · doi:10.1159/000473882 · Cited by 54
Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis
Kitz, J., Lowes, L. E., Goodale, D. B., & Allan, A. L. (2018) · Diagnostics · doi:10.3390/diagnostics8020030 · Cited by 34
Cell lines from circulating tumor cells
Pantel, K., & Alix‐Panabières, C. (2015) · Oncoscience · doi:10.18632/oncoscience.195 · Cited by 32
Remón, J., & Majem, M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.10.14 · Cited by 31
Genetic Heterogeneity in Colorectal Cancer and its Clinical Implications
Barranha, R., Costa, J. L., Carneiro, F., & Machado, J. C. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5398 · Cited by 14
Lowe, A. C.-Y. (2018) · Surgical pathology clinics · doi:10.1016/j.path.2018.04.008 · Cited by 13
Cited by
T cell-engaging therapies — BiTEs and beyond
Goebeler, M.-E., & Bargou, R. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0347-5 · Cited by 644
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Zhang, A., Miao, K., Sun, H., & Deng, C.-X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72534 · Cited by 352
Network approach in liquidomics landscape
Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02743-9 · Cited by 37
Liquid biopsy: creating opportunities in brain space
Trivedi, R., & Bhat, K. P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02446-0 · Cited by 27
Metadata
- Authors
- Poulet, G., Massias, J., & Taly, V.
- Venue
- Acta Cytologica
- Publisher
- S. Karger AG
- Published
- 2019
- Volume
- 63
- Issue
- 6
- Pages
- 449-455
- ISSN
- 0001-5547 (ISSN-L)
- 1938-2650
- OpenAlex
- W2944942638
- Cited by
- 332
- References
- 62
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.